Search

everythinglearnresearchcommunity

for

Search:↓

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

Elf5 controls skin cell growth and development, making it a potential target for skin treatments.

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

Google should ban ads targeting cancer patients with sensitive health-related keywords to protect them from misleading information.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

A new method using a microfluidic device can prepare hair follicle germs efficiently for potential use in hair loss treatments.

Alopecia greatly affects Greek women's daily life, relationships, and self-image, with mixed social support and dissatisfaction with treatments.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

The document concludes that specific methods for making diazine-based drugs can lead to high yields and are important for creating effective treatments for various diseases.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Skin stem cells interacting with their environment is crucial for maintaining and regenerating skin and hair, and understanding this can help develop new treatments for skin and hair disorders.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Hair loss in men is common, treatable, but not curable.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Low fluence photoepilation temporarily removes hair by targeting the hair follicle's pigmented area without severe damage.

The conclusion is that genetic differences affect how the cochlea heals after hair cell loss, which may challenge the creation of hearing loss treatments.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Two distinct pathways direct proteins to vacuoles in Arabidopsis, affecting root hair growth and protein targeting.

Excipients greatly affect how well curcumin nanocrystals penetrate the skin and target hair follicles.

STAT5 activation is crucial for starting the hair growth phase.

Researchers developed a mouse model that successfully mimics the bladder damage seen in humans after radiation therapy.